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INTRODUCTION 
According to the Wound Healing Society, a wound is the 
result of disruption of normal anatomic structure and 
function. Based on the nature of repair process, wound can 
be classified as acute or chronic wounds
1
. The 
management of wounds can be done by using different 
wound dressings which have been developed over the 
years from the crude applications of plant herbs, animal fat  
and honey to tissue engineered scaffolds
2
. Recognition of 
the importance of clean liness and good aseptic practice in  
medicine and surgery has lead to improvements in the 
management of quality of wound management materials
3
. 
In the last few decades lot of work have been done towards 
effective management of wound. In the present scenario of 
advanced technology, modern wound dressing have been 
introduced which include hydrocolloid dressing, 
alginate/chitosan dressing and hydrogel dressing not only 
as bandage but also in the form of sponges, fiber, films and 
solution
4
.
 
Chitosan is currently receiving a great deal of 
attention for medical and pharmaceutical applications due 
to its beneficial intrinsic properties. Chitosan is a 
deacetylated chitin derivative containing amino sugar. 
Chitosan possess many properties that are advantageous 
for wound dressing, namely bio-compatibility, bio-
degradability, haemostatic activity, anti-infection and 
wound acceleration properties
5
. Alginate is another 
polymer which is bio-degradable and obtained from 
natural orig in having wound healing property and good 
bio-adhesion which is necessary for more retention over 
the skin
6
. Prajapati et al worked on polyelectrolyte 
complex of chitosan alginate for local drug delivery and 
explain that combination of appropriate drug and chitosan 
can help to recover topical infections. Polyelectrolyte 
complex film of ch itosan and sodium alginate film can be 
used for sustained drug delivery of potent antimicrobial 
and antifungal drugs by transdermal drug delivery
7
. Aloe 
vera also known as true or medical aloe is species of 
succulent plant, which is used as herbal medicine. Aloe 
vera is used topically and systemically for the treatment of 
different diseases. Aloe vera could improve wound healing 
after topical applicat ion by the different mechanisms, such 
as keeping the wound moist, increase epithelial cell 
migrat ion and more rapid maturation of co llagen and 
reduction in inflammation. Aloe vera has skin hydration 
effects, anti-microbial and anti-fungal act ivity
8
. The 
purpose of applying antibiotics and other antibacterial is 
mainly to prevent or combat infections especially for 
diabetic foot ulcers, surgical and accidents wound where 
the incident of infections can be high due to reduced 
resistance resulting from extreme trauma
9
. Mupirocin is a 
topical antimicrobial indicated in the treatment of impetigo 
and secondary skin infections.  Mupirocin is an antibiotic 
produced from pseudomonas fluorescens and structurally 
unrelated to any other topical or systemic antib iotic. 
Commercially it is available in the form of creams and 
ointments for topical application
10
.  
Hence in the present work an attempt will be made to 
prepare and evaluate polymeric composite films of 
chitosan-alginate and incorporated with mupirocin and 
aloe vera ext racts for the effective management of 
different types of wounds. 
MATERIALS AND METHOD 
Chitosan was obtained as gift sample from India Sea 
Foods, Cochin, Kerala and mupirocin was obtained as gift 
sample from Glen mark Pharmaceuticals Ltd, Nasik, Pune. 
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Aloe vera was obtained from the Bio-max Life Sciences, 
Hyderabad. 
1. Preparation of polymer composite films
 
The films were prepared by solvent casting method
11
 as 
shown in Table 1. Po lymeric films of ch itosan alone and 
along with aloe vera was prepared by dispersing specified 
amount of chitosan  dispersed in 3% v/v lact ic acid  in  
water, ag itated for 1 h and add aloe vera into the chitosan 
dispersion followed by addition of glutaraldehyde with 
gentle stirring, then add the propylene glycol. The mixed  
solution was left to stand until air bubbles had disappeared, 
then poured onto a petri dish and allowed to air-dry at  
40°C for 24 h.
 
To prepare chitosan-alginate composite 
films, sodium alg inate solution was  prepared by dissolving 
the alginate alone and along with aloe vera in the deionised 
water followed by chitosan solution which was prepared 
by dispersion of the chitosan in to 3% v/v lactic acid. 
Acetone was added to alginate solution. Finally the 
dispersed solution of the chitosan was added to sodium 
alginate solution drop wise under rapid  agitation, then 
glutaraldehyde (0.03% v/v) was added followed by 
propylene glycol. The casting and drying of the films was 
done similar as explained above.
8 
Similarly mupirocin  
incorporated films were prepare by adding mupirocin in  
alginate solution and followed the same procedure as 
explained above. 
Table 1: Formulation of polymer composite films  
Ingredients (% w/v) F1  F2  F3  F4  F5  F6  F7  F8  F9  F10 F11 F12 
Chitosan 3 3 2 2 1.5 1.5 1 1 1.5 1.5 1 1 
Sodium alg inate -- -- -- -- 1.5 1.5 1 1 1.5 1.5 1 1 
Aloe vera -- -- 1 1 -- -- 1 1 -- -- 1 1 
Mupirocin -- -- -- -- -- -- -- -- 2 2 2 2 
Glutaraldehyde -- 0.03 -- 0.03 -- 0.03 -- 0.03 -- 0.03 -- 0.03 
Propylene Glycol 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
 
2. Characterization of polymer composite films 
 
2.1 Foureir-transformation infrared s pectroscopy 
(FTIR) 
The drug-polymer and polymer-polymer interaction were 
studied using FTIR spectrometer (Perkin-Elmer (spectrum-
100) Japan) by taking 2% w/w of the sample with respect 
to potassium bromide disc, ground in to a fine powder and 
then compressed into a discs in a hydraulic press. Each 
disc was scanned 16 times at 2 mm/sec at a resolution of 4 
cm
-1
 using adopization. The characteristics peaks were 
recorded. 
3. Evaluation of polymer composite films 
3.1 Thickness
7 
The thickness of film influence the time required to absorb 
the polymer into the body. To determine the uniformity in  
thickness of film and change in thickness film after drug 
loading, it was measured for each film using screw gauge 
at three different sites of the film and the mean was 
calculated.  
3.2 Folding endurance
 
It was determined to find the flexibility of film which is 
needed to handle the film easily and for comfortable, 
secured application of film on the wound. It was 
determined by repeatedly folding one film at same place 
till it breaks or folded up to 300 times manually. The 
number of times of film could be folded at the same place 
without breaking give the value of fo lding endurance
12
. 
3.3 Swelling index
 
Weighed pieces (1cm
2
) of film were immersed in distilled 
water, then soaked films were removed from the medium 
at predetermined time, blotted to remove excess liquid and 
weighed immediately
12
. The swelling index was calculated 
as       . 
Where and  are the weight of the film before and 
after immersion in the medium. 
3.4 Water vapour penetration
 
 To measure the water vapour penetration, the films were 
cut and placed on top of open 2.5- cm bottles containing 
5g of silica gel and held in place with a screw lid (test area: 
4.9 cm
2
). The bottles were conditioned in desiccators 
containing silica gel fo r 12 h. The bottles were then placed 
in desiccators containing a saturated solution of sodium 
chloride at 75 % RH. The equilibrium vapour penetration 
was determined by weighing the bottles at 0, 12, 24 and 48 
hours respectively
12
. 
3.5 Tensile strength
14 
The mechanical p roperties of films were evaluated using a 
texture analyzer (Instron Universal Model) equipped with 
a 500 gm load cell
13
. Film strip in 10 mm X 10 mm of 
dimension and free from air bubbles or physical 
imperfections, was held between two clamps positioned at 
a distance of 1 cm. During measurement, the film was 
pulled by top clamp at a rate of 10mm/minutes. The force 
and elongation were measured when the films broke. The 
tensile strength was calculated as, 
Tensile strength (kg/mm
2
) = Breaking fo rce (kg)/Cross 
sectional area of sample (mm
2
) 
3.6 Invitro bioadhesion study
 
The bioadhesive property of the film was performed using 
an in-house pulley system instrument
13
. The proximal 
portion of a chicken pouch was used to represent the 
mucous-like texture of a fresh wound. The freshly 
slaughtered chicken pouch washed with physiological 
saline at 4°C and attached to a platform (test area: 4.9 
cm
2
). A prewetted film was placed a top the chicken pouch 
and held under 100 g weight for 2 min, with the other side 
of the weight connected to a pulley system. The water was 
added to a container attached to the pulley system until the 
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film was detached. The weight of water needed to detach 
the film from the intestine was recorded. 
3.7 Wound healing activity by excision model
 
Male Wister alb ino rats (150-250 g) in a total 8 groups of 
each having three animals were used after obtaining 
approval from institutional animal ethics committee 
(No.346/CPCSEA) by excision wound model
13,14,15
. 
Animals were housed under standard conditions of 
laboratory. Excision wound was inflicted under light ether 
anesthesia by excising a circular piece of (20 mm
2
) of full 
thickness skin from the dorsal interscapular region. 
Selected films were adhering over the wound and 
marketed povidone-iodine was used as a standard. Wound 
contraction was monitored by measuring wound area 
planimetrically, every alternate day till the wound was 
completely healed. Wound contraction was calculated as 
percent reduction in wound. 
RES ULTS AND DISCUSS UION 
In the present study natural based polymer composite films  
were prepared for the effect ive management of wound. To 
enhance the therapeutic efficacy of the film antimicrobial 
agents like mupirocin and wound healing accelerators like 
aloe vera was incorporated in the film. Chitosan and 
sodium alginate was used as main polymers alone and 
along with aloe vera was followed by glutaraldehyde as 
cross linking agent and propylene glycol as a plasticizer. 
All the films were prepared by solvent casting method. 
The characterization of prepared polymer composite films  
was studied by FTIR (Fourier’s  transform in frared  
spectroscopy) and the obtained spectra are represented in 
Figure 1. The IR study confirms that mupirocin remains 
intact in the polymer composite and also the IR spectrum 
of chitosan with sodium alginate results in format ion of 
ionic complexes as both the polymers are polyionic. 
Chitosan contains cationic amino group which interact 
ionically with anionic carboxylic group of alginate and 
further glutaraldehyde crosslinked within chitosan to form 
strong ionic complex. 
 
 
 
 
Figure 1: FTIR spectra of mupirocin loaded polymer composite films
Saleem et al                                                                             Journal of Drug Delivery & Therapeutics; 2012, 2(3): 167-172   
© 2011, JDDT. All Rights Reserved                                                  ISSN: 2250-1177                                              CODEN: JDDTAO  
All the polymer composite films were evaluated for different 
parameters and results are tabulated in Table 2. The 
thickness was varied from 0.6 to 1.0 mm as the total polymer 
concentration was kept constant (3% w/w).  Chitosan-
alginate composite films along with aloe vera without 
glutaraldehyde showed the thickness 0.6 ± 0.0577 mm. The 
thickness of the films was increased when the cross linker 
was added. The water vapour penetration of films had 
showed the percent increase in weight as shown in Table 2, 
from 26.22 ± 0.66% to 77.94 ± 0.89%. The water vapour 
permeability of the films was decrease with the increase in 
the concentration of the chitosan in the films. Thickness and 
the water vapour permeability inversely related, with 
thinnest films showed the highest water vapour permeability 
and vice-versa. The water vapour permeability of the 
mupirocin incorporated films showed from 28.44 ± 0.68% to 
65.23 ± 0.99%.  
Table 2: Evaluation parameters of polymer composite films  
FC Thickness 
(mm) 
Folding 
endurance 
Water Vapor 
penetration (% ) 
Tensile strength 
(Kg/mm
2
) 
Maximum swelling 
index (% ) 
In-vitro bioadhesion 
gm/cm
2
 
F1  0.8 ± 0.05 235 ± 5.21 61.61  ± 1.22 0.122 ± 0.01 2542.85 ±12.22 21.28 ±0 .58 
F2 1 ± 0.06 258 ± 2.86 26.22  ± 0.66 0.296 ± 0.02 1114.28 ± 8.22 11.59 ± 0.64 
F3 0.7 ±  0.05 177 ± 2.52 77.94  ± 0.89 0.128 ± 0.01 1811.11 ± 9.05 19.24 ± 0.44 
F4 0.8 ± 0.07 210 ± 2.05 32.80  ± 0.45 0.266 ± 0.01 922.22 ± 7.94 12.47 ± 0.33 
F5 0.7 ±  0.07 194 ± 4.51 77.66  ± 0.42 0.258 ± 0.02 2900 ± 13.12 26.98 ± 0.39 
F6 0.9 ± 0.05 219 ± 3.25 57.33  ±0 .88 0.294 ± 0.04 1144.44 ± 8.99 25.95 ± 0.54 
F7 0.6 ±  0.05 208 ± 2.25 68.42  ± 0.58 0.244 ± 0.08 2340 ± 12.58 26.12 ± 0.45 
F8 0.9 ± 0.06 222 ± 2.51 48.44  ± 0.64 0.276 ± 0.06 1266.66 ±13.52 24.25 ± 0.77 
F9 0.8 ±  0.05 195  ± 3.52 65.23 ± 0.99 0.245 ± 0.02 911.70 ± 7.42 22.12 ± 0.59 
F10 1  ± 0.03 214 ± 8.14 30.0 ± 1.01 0.296 ± 0.02 724.42 ± 7.92 21.41 ± 0.12 
F11 0.7 ±  0.05 211 ± 3.61 47.35 ± 0.68 0.242 ± 0.06 965.29 ± 7.35 22.66 ± 0.31 
F12 0.9 ± 0.05 210 ± 5.21 28.44 ± 0.65 0.278 ± 0.05 850 ± 6.75 20.25 ± 0.78 
(FC= Formulation Cod          Note: Values in parenthesis are standard deviation (±SD); n=3) 
The tensile strength of polymer composite films expressed in 
Kg/mm
2
 as depicted in Table 2. Tensile strength represents 
the mechanical property of the films for the safe handling of 
dressing. Tensile strength depends upon the polymer, 
presence of plasticizer and addition of glutaraldehyde. The 
tensile strength of polymer composite films was 0.122 ± 
0.0115 to 0.296 ± 0.0130 Kg/mm
2
. The results suggested 
that films containing glutaraldehyde showed decrease in 
tensile strength due to more flexib ility of films as compared 
to films did not contained glutaraldehyde. The addition of 
mupirocin in the chitosan-alginate composite films did  not 
affect the tensile strength. 
All the prepared polymer composite films were evaluated for 
bioadhesion and results are depicted in Table 2. The 
bioadhesion is an important property required to adhere to 
the wound for effective healing of the wound. The 
bioadhesion is affected by nature and molecular weight of 
polymer used, presence of cross  linker, contact time and the 
degree of swelling of polymer. Chitosan and alginates are 
highly hydrophilic cationic and anionic polymers and 
hydrated to form slightly adhesive mucilage. The 
bioadhesion of polymer composite films  was in the range of 
11.59 ± 0.69 to 26.98 ± 0.39. The bioadhesion was 
decreased by the addition of glutaraldehyde. The addition of 
mupirocin in the chitosan-alginate composite films did  not 
affect the bio-adhesion. All the prepared composite films 
were evaluated for swelling index, and average swelling 
index is depicted in Table 2 and also the data up to 9 h  is 
represented in figure 2 & 3. 
 
 
Figure 2: Swelling study of polymer composite films with 
and without glutaraldehyde along with aloe vera  
 
 
Figure 3: Swelling study of mupirocin incorporated polymer 
composite films with and without glutaraldehyde along with 
aloe vera  
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The swelling behavior is related with the mucoadhesion and 
depends on the nature and viscosity of polymer, media used 
and the presence of cross linker. The degree of swelling 
increased as the time passes and at certain time some of the 
formulat ions loose the integrity which did contained 
glutaraldehyde. In the chitosan composite films , chitosan 
alone showed rapid swelling up to 6 h and could not hold the 
shape, whereas addition of aloe vera prolonged the swelling 
up to 9 h. The percent swelling of polymer composite films 
was from 911.70 ± 7.42 to 2900 ± 13.12 (F1-F8). Mupirocin 
incorporated films showed the swelling from 724.42 ± 7.92 
to 965.29 ± 7.35 (F9-F12). Addition of glutaraldehyde 
decreased the swelling due to format ion of more rigid 
network. Wound healing is a process by which damaged 
tissue is restored as closely as possible to its normal state. 
Wound contraction is the process of shrinkage of area of the 
wound. It mainly depends on the repairing ability of tissue, 
which may be reduced due to infection. Chitosan-alginate 
composite films containing aloe vera and mupirocin with 
and without glutaraldehyde were subjected to in vivo wound 
healing activity by method of excision model in albino rats. 
The results are expressed in percent contraction in wound 
area as depicted in Table 3 & 4 and also represented in bar 
graph in figure 4 and 5.  
Table 3: Wound healing data of polymer composite films formulated with and  without glutaraldehyde along with aloe vera  
Post- 
wounding 
days 
Wound area (mm) 
Control Standard F5  F6  F7  F8  
0 20.03 ± 0.81 
(0%) 
20.35 ± 0.76 
(0%) 
20.06 ± 0.42 
(0 %) 
19.92 ± 0.93 
(0%) 
19.95 ± 0.56 
(0 %) 
19.98 ± 0.78 
(0%) 
2 18.06 ± 0.77      
(9.7%) 
18.02 ± 0.52 
(9.9%) 
17.52 ± 0.63 
(12.4 %) 
17.12 ± 0.84 
(19.4%) 
16.65 ± 0.92 
(16.75 %) 
16.12 ± 0.06 
(19.4 %) 
4 16.09 ± 0.32 
(19.6%) 
15.69 ± 0.53 
(21.55 %) 
15.5 ± 0.29 
(22.2 %) 
18.24 ± 0.25 
(24.4 %) 
13.95 ± 0.69 
(30.25 %) 
13.25 ± 0.55 
(33.75%) 
6 15.03 ± 0.88 
(24.55%) 
13.46 ± 1.20 
(32.7 %) 
12.98 ± 0.95 
(35.1 %) 
12.22 ± 1.29 
(39%) 
6.8 ± 0.25 
(67.5 %) 
6.12 ± 0.99 
(69.4%) 
8 14.07 ± 1.04 
(29.65%) 
12.5 ± 0.5 
(37.5 %) 
6.98 ± 0.46 
(65.1 %) 
6.25 ± 0.25 
(68.25 %) 
3.25 ± 0.32 
(83.75%) 
3.06 ± 0.84 
(84.7%) 
10 13.04 ±0.62 
(34.85%) 
9.35 ± 0.94 
(53.25 %) 
3.21 ± 1.25 
(83.95 %) 
3.12 ± 0.15 
(84.14 %) 
1.75 ± 0.57 
(91.25 %) 
1.53 ± 0.28 
(92.35 %) 
12 10.09 ± 0.40 
(49.55 %) 
4.04 ± 0.38 
(79.55 %) 
1.5 ± 0.05 
(92.5 %) 
1.4 ± 0.84 
(93 %) 
0.87 ± 0.46 
(95.65 %) 
0.76 ± 0.24 
(96.5%) 
(Values are mean ± SD of three animals in each group. Numbers in parenthesis indicates the % wound contraction) 
Table 4: Wound healing data of mupirocin loaded chitosan-alginate composite films fo rmulated with and without 
glutaraldehyde along with aloe vera  
Post- 
wounding 
days 
Wound area (mm) 
Control Standard F9  F10 F11 F12 
0 20.03 ± 0.81 
(0%) 
20.35 ± 0.76 
(0%) 
20.02 ± 0.79 
(0%) 
19.98 ± 0.32 
(0%) 
19.98 ± 0.65 
(0%) 
19.25 ± 0.65 
(0%) 
2 18.06 ± 0.77      
(9.7%) 
18.02 ± 0.52 
(9.9%) 
17.14 ± 0.93 
(14.13%) 
17.01 ± 0.49 
(14.95%) 
15.92 ± 0.77 
(20.4%) 
15.95 ± 0.24 
(20.25%) 
4 16.09 ± 0.32 
(19.6%) 
15.69 ± 0.53 
(21.55 %) 
14.92 ± 1.26 
(25.4%) 
14.91 ± 0.86 
(25.45%) 
13.13 ± 1.11 
(34.35%) 
12.92 ± 0.14 
(35.25%) 
6 15.03 ± 0.88 
(24.55%) 
13.46 ± 1.20 
(32.7 %) 
12.25 ± 0.22 
(38.75%) 
12.01 ± 0.69 
(39.45%) 
6.14 ± 0.28 
(69.3%) 
6 ± 0.29 
(70%) 
8 14.07 ± 1.04 
(29.65%) 
12.5 ± 0.5 
(37.5 %) 
6.25 ± 0.38 
(68.75%) 
5.84 ± 0.26 
(70.75%) 
2.92 ± 0.29 
(85.4%) 
2.98 ± 0.94 
(85%) 
10 13.04 ±0.62 
(34.85%) 
9.35 ± 0.94 
(53.25 %) 
3.14 ± 1.43 
(84.3%) 
2.95 ± 0.82 
(89.25%) 
1.4 ± 0.22 
(93%) 
1.32 ± 0.46 
(93.4%) 
12 10.09 ± 0.40 
(49.55 %) 
4.04 ± 0.38 
(79.55 %) 
1.1 ± 0.21 
(94.5%) 
1.25 ± 0.28 
(93.75%) 
0.22 ± 0.06 
(98.9%) 
0.12 ± 0.04 
(99.4%) 
(Values are mean ± SD of three animals in each group. Numbers in parenthesis indicates the % wound contraction) 
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Figure 4: Comparative %wound healing of control and standard 
with polymer composite films formulated with and without 
glutaraldehyde containing aloe vera 
All the plane chitosan composite films without 
glutaraldehyde showed increase in % wound contraction as 
compared to control and standard at 12
th 
day. Control 
showed 49.55%, standard 79.55% where as F5 showed 
92.5% and F7 95.65%. The chitosan-alginate composite 
films prepared with glutaraldehyde showed percentage of 
wound contraction as F6 93% and F8 96.5%. The results of 
addition of glutaraldehyde in the chitosan-alginate did not 
show much deviation as compared to films without 
glutaraldehyde. Aloe vera is ancient herbal medicine used as 
a wound healing accelerator because of its anti-microbial 
effect, anti-fungal activity and epitheliazat ion of damaged 
tissue cells.  Mupirocin is a broad spectrum topical 
antibiotic. Mupirocin loaded chitosan-alginate composite 
films showed % maximum wound contraction of 94.5% for 
F9, 93.75% for F10, 98.9% for F11 and 99.4% for F12. 
These results suggested that addition of mupirocin further 
accelerate the healing by prevention of secondary wound 
infections and the wound was completely healed with in 12 
days as shown in figure 6. 
 
Figure 5: Comparative %wound healing of control and standard 
with mupirocin incorporated polymer composite films formulated 
with and without glutaraldehyde containing aloe vera 
      
Figure 6: Completely healed wound after 12th day for mupirocin loaded polymer composite films F11 & F12 
CONCLUS ION 
The chitosan polymer composite films containing 
glutaraldehyde as crosslinker have uniform thickness with 
good flexibility, good tensile strength, absorb more moisture 
with excellent bioadhesion and good swelling. All the 
polymeric films showed more than 80% reduction in wound 
contraction. The mupirocin loaded polymeric composite 
containing aloe vera, showed more than 98% of reduction in 
wound area after 12
th
 day. Hence it can be concluded that 
mupirocin incorporated chitosan-alginate films along with 
aloe vera containing glutaraldehyde may be excellent new 
dressing for wound occlusion/tissue repairing and could be 
used for effective treatment of all types of wound. Hence 
mupirocin incorporated chitosan-alginate films along with 
aloe vera containing glutaraldehyde may be promising new 
dressing for wound occlusion/tissue repairing and could be 
used for effect ive treatment of all types of wound. 
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